Leucosceptoside A from Devil’s Claw Modulates Psoriasis-like Inflammation via Suppression of the PI3K/AKT Signaling Pathway in Keratinocytes

Psoriasis is a chronic inflammatory skin condition characterized by abnormal keratinocyte proliferation and differentiation that is accompanied with dysregulated immune response and abnormal vascularization. Devil’s claw (<i>Harpagophytum procumbens</i> (Burch.) DC. ex Meisn.) tubers ext...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ivanka K. Koycheva, Liliya V. Mihaylova, Monika N. Todorova, Zhivka P. Balcheva-Sivenova, Kalina Alipieva, Claudio Ferrante, Giustino Orlando, Milen I. Georgiev
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/99b65710ec314300a165d3fbc4a59782
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:99b65710ec314300a165d3fbc4a59782
record_format dspace
spelling oai:doaj.org-article:99b65710ec314300a165d3fbc4a597822021-11-25T18:29:11ZLeucosceptoside A from Devil’s Claw Modulates Psoriasis-like Inflammation via Suppression of the PI3K/AKT Signaling Pathway in Keratinocytes10.3390/molecules262270141420-3049https://doaj.org/article/99b65710ec314300a165d3fbc4a597822021-11-01T00:00:00Zhttps://www.mdpi.com/1420-3049/26/22/7014https://doaj.org/toc/1420-3049Psoriasis is a chronic inflammatory skin condition characterized by abnormal keratinocyte proliferation and differentiation that is accompanied with dysregulated immune response and abnormal vascularization. Devil’s claw (<i>Harpagophytum procumbens</i> (Burch.) DC. ex Meisn.) tubers extract has been used both systemically and topically for treatment of chronic inflammatory diseases such as arthritis, osteoporosis, inflammatory bowel disease, among others. However, its potential mechanisms of action against psoriasis remains poorly investigated. The human keratinocyte HaCaT cell line is a well-accepted in vitro model system for inflammatory skin disorders such as psoriasis. The present study involved an exploration of the effect of biotechnologically produced <i>H. procumbens</i> (HP) cell suspension extract and pure phenylethanoid glycosides verbascoside (VER) and leucosceptoside A (LEU) in interferon (IFN)-γ/interleukin (IL)-17A/IL-22-stimulated HaCaT cells as a model of psoriasis-like inflammation. Changes in key inflammatory signaling pathways related to psoriasis development were detected by reverse transcription polymerase chain reaction and western blotting. Treatment with LEU, but not VER and HP extract improved psoriasis-related inflammation via suppression of the PI3K/AKT signaling in IFN-γ/IL-17A/IL-22-stimulated HaCaT cells. Our results suggest that LEU may exhibit therapeutic potential against psoriasis by regulating keratinocyte differentiation through inhibition of the PI3K/AKT pathway.Ivanka K. KoychevaLiliya V. MihaylovaMonika N. TodorovaZhivka P. Balcheva-SivenovaKalina AlipievaClaudio FerranteGiustino OrlandoMilen I. GeorgievMDPI AGarticlepsoriasiskeratinocytesinflammationverbascosideleucosceptoside Adevil’s clawOrganic chemistryQD241-441ENMolecules, Vol 26, Iss 7014, p 7014 (2021)
institution DOAJ
collection DOAJ
language EN
topic psoriasis
keratinocytes
inflammation
verbascoside
leucosceptoside A
devil’s claw
Organic chemistry
QD241-441
spellingShingle psoriasis
keratinocytes
inflammation
verbascoside
leucosceptoside A
devil’s claw
Organic chemistry
QD241-441
Ivanka K. Koycheva
Liliya V. Mihaylova
Monika N. Todorova
Zhivka P. Balcheva-Sivenova
Kalina Alipieva
Claudio Ferrante
Giustino Orlando
Milen I. Georgiev
Leucosceptoside A from Devil’s Claw Modulates Psoriasis-like Inflammation via Suppression of the PI3K/AKT Signaling Pathway in Keratinocytes
description Psoriasis is a chronic inflammatory skin condition characterized by abnormal keratinocyte proliferation and differentiation that is accompanied with dysregulated immune response and abnormal vascularization. Devil’s claw (<i>Harpagophytum procumbens</i> (Burch.) DC. ex Meisn.) tubers extract has been used both systemically and topically for treatment of chronic inflammatory diseases such as arthritis, osteoporosis, inflammatory bowel disease, among others. However, its potential mechanisms of action against psoriasis remains poorly investigated. The human keratinocyte HaCaT cell line is a well-accepted in vitro model system for inflammatory skin disorders such as psoriasis. The present study involved an exploration of the effect of biotechnologically produced <i>H. procumbens</i> (HP) cell suspension extract and pure phenylethanoid glycosides verbascoside (VER) and leucosceptoside A (LEU) in interferon (IFN)-γ/interleukin (IL)-17A/IL-22-stimulated HaCaT cells as a model of psoriasis-like inflammation. Changes in key inflammatory signaling pathways related to psoriasis development were detected by reverse transcription polymerase chain reaction and western blotting. Treatment with LEU, but not VER and HP extract improved psoriasis-related inflammation via suppression of the PI3K/AKT signaling in IFN-γ/IL-17A/IL-22-stimulated HaCaT cells. Our results suggest that LEU may exhibit therapeutic potential against psoriasis by regulating keratinocyte differentiation through inhibition of the PI3K/AKT pathway.
format article
author Ivanka K. Koycheva
Liliya V. Mihaylova
Monika N. Todorova
Zhivka P. Balcheva-Sivenova
Kalina Alipieva
Claudio Ferrante
Giustino Orlando
Milen I. Georgiev
author_facet Ivanka K. Koycheva
Liliya V. Mihaylova
Monika N. Todorova
Zhivka P. Balcheva-Sivenova
Kalina Alipieva
Claudio Ferrante
Giustino Orlando
Milen I. Georgiev
author_sort Ivanka K. Koycheva
title Leucosceptoside A from Devil’s Claw Modulates Psoriasis-like Inflammation via Suppression of the PI3K/AKT Signaling Pathway in Keratinocytes
title_short Leucosceptoside A from Devil’s Claw Modulates Psoriasis-like Inflammation via Suppression of the PI3K/AKT Signaling Pathway in Keratinocytes
title_full Leucosceptoside A from Devil’s Claw Modulates Psoriasis-like Inflammation via Suppression of the PI3K/AKT Signaling Pathway in Keratinocytes
title_fullStr Leucosceptoside A from Devil’s Claw Modulates Psoriasis-like Inflammation via Suppression of the PI3K/AKT Signaling Pathway in Keratinocytes
title_full_unstemmed Leucosceptoside A from Devil’s Claw Modulates Psoriasis-like Inflammation via Suppression of the PI3K/AKT Signaling Pathway in Keratinocytes
title_sort leucosceptoside a from devil’s claw modulates psoriasis-like inflammation via suppression of the pi3k/akt signaling pathway in keratinocytes
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/99b65710ec314300a165d3fbc4a59782
work_keys_str_mv AT ivankakkoycheva leucosceptosideafromdevilsclawmodulatespsoriasislikeinflammationviasuppressionofthepi3kaktsignalingpathwayinkeratinocytes
AT liliyavmihaylova leucosceptosideafromdevilsclawmodulatespsoriasislikeinflammationviasuppressionofthepi3kaktsignalingpathwayinkeratinocytes
AT monikantodorova leucosceptosideafromdevilsclawmodulatespsoriasislikeinflammationviasuppressionofthepi3kaktsignalingpathwayinkeratinocytes
AT zhivkapbalchevasivenova leucosceptosideafromdevilsclawmodulatespsoriasislikeinflammationviasuppressionofthepi3kaktsignalingpathwayinkeratinocytes
AT kalinaalipieva leucosceptosideafromdevilsclawmodulatespsoriasislikeinflammationviasuppressionofthepi3kaktsignalingpathwayinkeratinocytes
AT claudioferrante leucosceptosideafromdevilsclawmodulatespsoriasislikeinflammationviasuppressionofthepi3kaktsignalingpathwayinkeratinocytes
AT giustinoorlando leucosceptosideafromdevilsclawmodulatespsoriasislikeinflammationviasuppressionofthepi3kaktsignalingpathwayinkeratinocytes
AT milenigeorgiev leucosceptosideafromdevilsclawmodulatespsoriasislikeinflammationviasuppressionofthepi3kaktsignalingpathwayinkeratinocytes
_version_ 1718411092637515776